Recital 17, Directive (EU) 2022/1326

In forcesince 18 Mar 2022

Fifteen Member States control 3-MMC under national drug control legislation, six Member States control it under new psychoactive substances legislation and one Member State controls it under other legislation. Thirteen Member States control 3-CMC under national drug control legislation, seven Member States control it under new psychoactive substances legislation and one Member State controls it under other legislation. Given that these national control measures are already in place, including 3-MMC and 3-CMC in the definition of ‘drug’ and thereby covering them by provisions on the criminal offences and sanctions as defined in Framework Decision 2004/757/JHA would help avoiding the emergence of obstacles in cross-border law enforcement and judicial cooperation, and would help protecting from the risks that their availability and use can pose.